Through its diverse research lines, the Research Group in Cutaneous Oncology develops new diagnostic, prognostic and therapeutic strategies aimed at improving the clinical management of patients with skin tumors and increasing both their life expectancy and quality. The studies carried out by this research group have resulted in the creation of guidelines for the practical management of patients, several doctoral theses and multiple articles published in highly prestigious scientific journals.
The Research Group in Cutaneous Oncology develops various lines of translational research aimed at identifying the genes involved in the onset and progression of cutaneous tumors, and at characterizing diagnostic and prognostic tumor markers, along with potential therapeutic targets. The research group also participates in the promotion and conduct of several phase II and III clinical trials enrolling patients with mycosis fungoides and melanoma.